Clinical Trials Sponsored by Spyridon Fortis

Total 731 results

Spyridon Fortis
American Thoracic Society

Recruiting

HHHFA in COPD Patients, With Chronic Bronchitis

Pulmonary Disease, Chronic Obstructive

United States
Spyridon Deftereos

Completed

Moxonidine for Prevention of Post-ablation AFib Recurrences

Atrial Fibrillation

Greece
Fortis Therapeutics, Inc.

Completed

A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Prostate Cancer Metastatic

United States
Fortis Therapeutics, Inc.

Completed

A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Multiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission

United States
Fortis Hospital, India

Unknown

Can Changes in Velocity Time Integral Serve as a Sensitive Indicator for Monitoring Changes in Stroke Volume ?

Ischemic Heart Disease
Fortis Memorial Research Institute

Terminated

Radiation- Induced Alopecia in Patients Undergoing Radiation Therapy to the Brain

Alopecia; X-Rays

India
Fortius Clinic

Unknown

Plantaris Release for Non-insertional Achilles Tendinopathy

Tendinopathy | Achilles Tendon

United Kingdom
Forbes Norris MDA/ALS Research Center
Muscular Dystrophy Association

Completed

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS) (Lithium)

Amyotrophic Lateral Sclerosis

United States
Forbes Norris MDA/ALS Research Center
Muscular Dystrophy Association

Completed

Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org

Amyotrophic Lateral Sclerosis

United States
Fortius Clinic

Unknown

Functional Improvement and UTC of the Achilles Tendon After Sodium Hyaluronate Injection for Plantaris Syndrome

Non-Insertional Achilles Tendinopathy | Plantaris Friction Syndrome

United Kingdom
Kakatiya University
Fortis Hospital, India

Completed

A Prescription Audit of Inpatient Department of Super Speciality Hospital in National Capital Region of India

Review of In-patient Prescription

India
Spyridon Deftereos
Biosense Webster, Inc.

Unknown

Prophylactic Substrate Ablation in Post-myocardial Patients Undergoing Defibrillator Implantation.

Myocardial Infarction | Heart Failure | Ventricular Tachycardia
ortis
CEN Biotech

Completed

Study on the Effect of Rhubarb Extract on Stool Frequency and Biological Markers of Intestinal Function in Seniors With Low Defecation

Constipation - Functional

France
Samuel Fortin

Terminated

Impact of Fish Oil Monoglycerides on the Modulation of Mitochondrial Functions and Lactate Threshold

Healthy Athletes

Canada
Samuel Fortin

Completed

Effect of Fish Oil Monoglycerides on the Omega-3 Index

Pharmacokinetic in Normal Population

Canada
Fortis Hospital, India
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Clinical Outcome in High Risk Patients Who Received Empirical Antifungal Therapy

Antifungal Therapy

India
Cordis Corporation

Completed

European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSIGHT)

Abdominal Aortic Aneurysms

United Kingdom, Netherlands, Ireland, Sweden, Germany, Italy, Spain, France
Cordis Corporation

No longer available

Compassionate Use of the Incraft® AAA Stent Graft System

Abdominal Aortic Aneurysm

United States
Cordis Corporation

Completed

S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease (STROLL)

Superficial Femoral Artery Disease

United States
Cordis Corporation

Terminated

An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II) (NEVO II)

Atherosclerotic Coronary Artery Disease

Spain, Switzerland, Netherlands
Cordis Corporation

Completed

The Intra-Drug Eluting Stent (DES) Restenosis Study (CRISTAL)

Coronary Artery Disease

France
Cordis Corporation

Completed

The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent (SUPER SL)

Arterial Occlusive Diseases

Germany
Cordis Corporation

Completed

A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions (SCORPIUS)

Coronary Artery Disease

Germany
Cordis Corporation

Completed

Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions (3D)

Coronary Artery Disease

Brazil
Cordis Corporation

Completed

Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)

Coronary Artery Disease

United States
Cordis Corporation

Completed

The Study to Assess AMI Treated With Balloon Angioplasty. (TYPHOON)

Coronary Artery Disease

France, Germany
Cordis Corporation

Completed

The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions. (E-SIRIUS)

Coronary Artery Disease

Germany
Cordis Corporation

Completed

Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)

Pulmonary Embolism
Cordis Corporation

Completed

Distal Protection Combined With PTCA in AMI Patients (DIPLOMAT)

Coronary Artery Disease

France
Cordis Corporation

Completed

FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

Coronary Artery Disease

Netherlands
Cordis Corporation

Completed

A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION) (INNOVATION)

Abdominal Aortic Aneurysms

Germany
Cordis Corporation

Completed

SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy

Carotid Artery Disease

United States
Cordis Corporation

Unknown

Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems (ELITE)

Coronary Artery Disease | Coronary Atherosclerosis

United States
Cordis Corporation

Terminated

Cynergy: the CYPHER-NEVO Registry (CYNERGY)

Coronary Artery Disease

Korea, Republic of, Brazil, Switzerland
Cordis Corporation

Completed

Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease (ACHILLES)

Peripheral Arterial Diseases

Germany
Cordis Corporation

Completed

A Study of the SMART Stent in the Treatment SFA Disease. (SIROCCO)

Peripheral Artery Disease

Germany
Cordis Corporation

Completed

A Multi-center Post-Market Surveillance Registry (E-SELECT)

Coronary Artery Disease

Switzerland
Cordis Corporation

Completed

Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)

In-Stent Restenosis

United States
Cordis Corporation

Completed

The Study to Compare SMART Nitinol Stent and Balloon Angioplasty (SIT-UP)

Superficial Femoral Artery Occlusions

Switzerland
Cordis Corporation

Completed

The Study to Treat Superficial Femoral Artery Occlusions. (SUPER UK)

Arterial Occlusive Diseases

United Kingdom
Cordis Corporation

Completed

The Arterial Revascularization Therapies Study Part II. (ARTS II)

Coronary Artery Disease

Netherlands
Cordis Corporation

Completed

Study of the Endovascular QUANTUM LP™ Stent Graft System in Abdominal Aortic Aneurysms (AAA)

Abdominal Aortic Aneurysm

United States
Cordis Corporation

Terminated

The Study to Compare the Treatment of Angioplasty and Stents in SFA Occlusions. (DURAVEST)

Arterial Occlusive Diseases

Netherlands
Cordis Corporation

Completed

The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity. (DISCOVER)

Coronary Artery Disease

Germany
Cordis Corporation

Completed

The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions. (DOMINO)

Coronary Artery Disease

United Kingdom
Cordis Corporation

Completed

A Comparison of Coated and Uncoated Stents in Renal Artery Treatment. (GREAT)

Renal Artery Stenosis

France, Germany, Netherlands
Cordis Corporation

Completed

A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions. (TROPICAL)

Coronary Artery Disease

Belgium, Germany
Cordis Corporation

Completed

A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions. (BIFURCATION)

Coronary Artery Disease

Italy
Cordis Corporation

Completed

A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)

Coronary Artery Disease
Cordis Corporation

Completed

FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent

Coronary Artery Disease

Brazil

3

Subscribe